Less than five months after getting approval for its laser-based anti-wrinkle device, Cynosure Inc. (Nasdaq: CYNO) has received clearance from the U.S. Food and Drug Administration to market the PicoSure laser workstation for the removal of tattoos and benign pigmented lesions.